Skip to main content
Fig. 11 | EJNMMI Radiopharmacy and Chemistry

Fig. 11

From: Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model

Fig. 11

Hematological analysis and H&E staining. A Hematological analysis showed that the WBC, RBC, HGB, MCH, and PLT counts of low- and high-dose and NY003-only groups decreased within the observation period (14 d p.i.). B The H&E staining results showed regional or focal necrosis within the tumors in low- and high-dose groups, especially the high-dose group, illustrating the therapeutic effect of [177Lu]Lu-DTPA-NY003. Hepatic congestion and splenic white pulp atrophy were observed in low- and high-dose and NY003-only groups

Back to article page